Advanced Applications and Biomedical Functions of Succinyl Cyclodextrin Derivatives

Advanced Applications and Biomedical Functions of Succinyl Cyclodextrin Derivatives

Our customer services representatives are available 24 hours a day, from Monday to Sunday.

CONTACT US
Online Inquiry
Verification code
Advanced Applications and Biomedical Functions of Succinyl Cyclodextrin Derivatives
INQUIRY

What Is Succinyl Cyclodextrin and Why Is It Important in Drug Delivery?

Succinyl cyclodextrins (SuCDs) are chemically modified cyclodextrins (CDs) that are functionalized with succinyl groups for specific pharmaceutical applications. They are succinylated derivatives of natural CDs with enhanced aqueous solubility, molecular recognition properties, and biocompatibility. CDs are cyclic oligosaccharides consisting of α-(1→4)-linked glucopyranose units with a hydrophobic central cavity and a hydrophilic exterior. This structure allows them to form host–guest inclusion complexes with a variety of poorly water-soluble drugs. Succinyl cyclodextrins are CDs functionalized with succinyl groups attached to the hydroxyl groups present on the CD backbone. The introduction of succinyl groups significantly changes the physicochemical and biological properties of these carriers. SuCDs can be used in sophisticated drug delivery systems.

Fig.1 Schematic diagram of the structure of succinyl cyclodextrin.Fig.1 Structure of succinyl cyclodextrin.

Alfa Chemistry offers succinylated derivatives of CDs, including Succinyl-α-CD (SACD), Succinyl-β-CD (SBCD), Succinyl-γ-CD (SuGCD), hydroxypropylated analogs (SuHPBCD, SuHPGCD). They are used in drug formulation, enzyme inhibition, nanotechnology, and chiral separation. Their superior solubilization and encapsulation properties enable improved bioavailability, targeted drug delivery, and controlled release systems.

Table: Comparison of Key Succinyl Cyclodextrin Derivatives

CompoundCavity SizeSolubilityIdeal Applications
Succinyl-α-CD (SACD)SmallModerateHydrophobic small molecule solubilization
Succinyl-β-CD (SBCD)MediumHighOral drug formulations, chiral separations
Succinyl-γ-CD (SuGCD)LargeVery HighProtein/peptide encapsulation, nanoparticle base
SuHPBCDMediumVery HighInjectable drugs, systemic delivery
SuHPGCDLargeVery HighGene and protein delivery, targeted release

Role of Succinylated Cyclodextrins in Drug Bioavailability

Enhanced Solubilizing Capacity: Succinyl substitution provides carboxylate functionalities that can further improve water solubility and ionization capacity of the parent CD. This can lead to a marked improvement in the solubilizing capacity of cyclodextrins for hydrophobic drugs. For example, Succinyl-β-CD (SBCD) was found to form strong inclusion complexes with a wide range of APIs, significantly improving their dissolution rate and in vivo absorption. Additionally, the amphiphilic nature of these derivatives can facilitate improved membrane permeability and reduced drug crystallization, enabling favorable pharmacokinetic properties.

Fig.2 Albendazole (ABZ) inclusion complexes in succinyl-β-cyclodextrin with two degrees of substitution.Fig.2 Study on the inclusion complex of albendazole (ABZ) in succinyl-β-cyclodextrin with two degrees of substitution[1].

Mucoadhesion and Physiological Stability: The presence of succinyl groups also imparts mucoadhesion and stability in physiological conditions, which is particularly advantageous for oral, pulmonary, and parenteral drug delivery. SuHPBCD and SuHPGCD with additional hydroxypropyl substitution can provide a further enhanced balance between hydrophilicity and complexation efficiency, enabling tunable drug loading and release kinetics.

Applications of Succinyl Cyclodextrins in Nanotechnology

Fabrication of Nanocarriers: In the context of nanomedicine, succinylated CDs have been extensively utilized for the fabrication of nanocarriers such as chitosan/SBCD nanoparticles and protein-loaded nanospheres. These systems have exhibited excellent biocompatibility, encapsulation efficiency, and controlled release behavior. For example, SBCD-based nanoparticles were reported to enable significant improvement in the sustained release of bovine serum albumin (BSA) as a model protein drug carrier.

Site-Specific Delivery and pH Responsiveness: Incorporation of SuCDs in nanoparticle matrices can not only improve solubility but also impart pH-responsive properties, given the ionizable nature of the succinyl groups. These properties can be exploited for site-specific drug delivery, such as tumor-targeted drug release and intracellular delivery.

Fig.3 Schematic diagram of the preparation of cyclodextrin nanoparticles.Fig.3 Schematic diagram of the preparation of cyclodextrin nanoparticles by cross-linking succinyl-β-cyclodextrin with L-lysine catalyzed by EDC/NHS, followed by fluorescent derivatization with the succinimidyl ester of AF555[2].

SuCDs as Enzyme Inhibitors and Metabolic Regulators

Some succinyl derivatives are known to act as enzyme inhibitors, for example, succinyl acetone, is a competitive inhibitor of δ-aminolevulinic acid dehydratase, and its use results in the disruption of heme biosynthesis. This mechanism is being exploited in clinical trials for the treatment of hereditary tyrosinemia type I.

SuCDs are also finding applications as enzyme modulators and stabilizers, with studies showing improved enzymatic selectivity and catalysis in biologically relevant environments.

Application of Succinylated CDs in Chiral Separation

Chiral recognition is an important aspect of the development of pure enantiomers of drug candidates. SuBCDs have been shown to outperform many other CD derivatives such as carboxymethyl-β-CD (in terms of efficacy) in certain chiral separations, attributed to the higher number of hydrogen bonding and electrostatic interactions in such complexes. These separation methodologies have been used in capillary electrophoresis and HPLC-based chiral separations, in which SUCDs showed superior peak symmetry and resolution compared to other CDs.

Fig.4 Catechins were separated by capillary electrophoresis using mono-, di- and trisuccinyl-b-cyclodextrin as chiral selectors.Fig.4 Catechins were separated by capillary electrophoresis using mono-, di- and trisuccinyl-b-cyclodextrin as chiral selectors. (a) Structures of (6)-catechin and succinyl-b-cyclodextrins.(b) Dependence of the chiral separation of (6)-catechin at pH 9.8 on the nature and concentration of Suc-β-CDs[3].

In Which Pharmaceutical Formulations Are SuCDs Commonly Used?

Succinyl CDs are utilized in diverse dosage forms including oral tablets, injectables, and inhalable formulations. Their ability to form inclusion complexes with insoluble drugs enhances formulation flexibility and stability. Moreover, their high water solubility ensures minimal toxicity and favorable pharmacodynamics. SuHPBCD, for example, is frequently used in parenteral preparations due to its low nephrotoxicity and excellent drug complexation capacity.

Alfa Chemistry provides pharmaceutical-grade SuCDs produced under GMP-compliant conditions for both R&D and commercial-scale manufacturing. We also offer custom synthesis for clients looking for particular substitution patterns or functionalized CD scaffolds for their specific applications.

Online Inquiry

Emerging Applications of Succinyl Cyclodextrins

SuCDs have also found applications outside of pharmaceutical applications, some of which include:

  • In biotechnology, SuCDs are used to modulate enzyme-catalyzed reactions and as protein stabilizers.
  • In agriculture, they are used as carriers for hydrophobic pesticides as well as plant growth regulators.
  • In cosmetics, SuCDs have been used to aid sustained fragrance release as well as stabilization of actives.
  • In food technology, these compounds have been used for flavor encapsulation and stabilization of nutrients.
  • In environmental science, SuCDs are being studied for pollutant sequestration and controlled release of bioremediation agents.

Fig.5 Succinyl-β-cyclodextrin modified gold biochip.Fig.5 Succinyl-β-cyclodextrin modified gold biochip to improve the sensitivity of Lyme disease serum immunoassay. The CD-modified biochip platform has a stronger affinity for VlsE protein[4].

FAQs About Succinyl Cyclodextrin

1. How do succinyl cyclodextrins differ from hydroxypropyl or methylated cyclodextrins?

Succinyl CD derivatives have carboxyl functional groups that confer pH sensitivity and ionic character, making them suitable for stimuli-responsive drug delivery, unlike neutral hydroxypropyl or methylated CDs.

2. Can succinyl cyclodextrins be used in injectable formulations?

Yes. Especially SuHPBCD and SBCD, which demonstrate excellent water solubility, low toxicity, and compatibility with various APIs for parenteral administration.

3. What determines the degree of substitution (DS) in succinyl CDs, and why does it matter?

DS refers to the average number of succinyl groups per cyclodextrin molecule. A higher DS generally increases water solubility and complexation ability, but may reduce binding specificity.

4. Are succinyl cyclodextrins biodegradable or metabolically inert?

They are considered non-toxic and largely excreted unchanged in urine. However, the exact metabolic fate depends on the degree of substitution and administration route.

5. Do SuCDs work for peptide or protein delivery?

Yes. SuCD-based nanoparticles have been proven to encapsulate and slowly release proteins like BSA, suggesting strong potential in protein or peptide therapeutics.

Alfa Chemistry's extensive collection of cyclodextrin derivatives delivers custom solutions for research and industrial needs across the globe.

References

  1. Priotti J., et al. (2018). "Succinyl-β-cyclodextrin: Influence of the substitution degree on albendazole inclusion complexes probed by NMR" Materials Science and Engineering: C, 92, 694-702.
  2. Soni SS., et al. (2024). "Uptake of Cyclodextrin Nanoparticles by Macrophages is Dependent on Particle Size and Receptor-Mediated Interactions." ACS Appl Bio Mater, 7(8), 4856-4866.
  3. Kim H., et al. (2009). "Chiral separation of catechin by capillary electrophoresis using mono-, di-, tri-succinyl-β-cyclodextrin as chiral selectors." Chirality, 21(10), 871-942.
  4. Ye L., et al. (20L17). "Succinyl-β-cyclodextrin modified gold biochip improved seroimmunological detection sensitivity for Lyme disease." Analytica Chimica Acta, 953, 48-56.

It should be noted that our our products and services are for research use only, not for clinical use.